These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28877838)

  • 21. Management and prevention of abnormal scars.
    Devlin-Rooney K; James W
    Nurs Stand; 2005 Mar 23-29; 19(28):45-54; quiz 55-6. PubMed ID: 15819267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hypertrophic scars and keloids.
    Kaartinen I
    Duodecim; 2016; 132(16):1439-47. PubMed ID: 29188931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modern treatment of keloids].
    Djoković R; Karadaglić Dj
    Srp Arh Celok Lek; 1997; 125(5-6):176-80. PubMed ID: 9265241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroproliferative scars.
    Rahban SR; Garner WL
    Clin Plast Surg; 2003 Jan; 30(1):77-89. PubMed ID: 12636218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertrophic scars and keloids.
    Haverstock BD
    Clin Podiatr Med Surg; 2001 Jan; 18(1):147-59. PubMed ID: 11344975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silicon gel sheeting for preventing and treating hypertrophic and keloid scars.
    O'Brien L; Pandit A
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003826. PubMed ID: 16437463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive scar formation by inhibiting TGF-β2/Smad3 signaling.
    Yuan R; Dai X; Li Y; Li C; Liu L
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. German S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids).
    Nast A; Eming S; Fluhr J; Fritz K; Gauglitz G; Hohenleutner S; Panizzon RG; Sebastian G; Sporbeck B; Koller J;
    J Dtsch Dermatol Ges; 2012 Oct; 10(10):747-62. PubMed ID: 22937806
    [No Abstract]   [Full Text] [Related]  

  • 30. Inflammation in Wound Healing and Pathological Scarring.
    Hong YK; Chang YH; Lin YC; Chen B; Guevara BEK; Hsu CK
    Adv Wound Care (New Rochelle); 2023 May; 12(5):288-300. PubMed ID: 36541356
    [No Abstract]   [Full Text] [Related]  

  • 31. Intralesional treatment for keloids and hypertrophic scars: a review.
    Ledon JA; Savas J; Franca K; Chacon A; Nouri K
    Dermatol Surg; 2013 Dec; 39(12):1745-57. PubMed ID: 24299571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management of hypertrophic scars and keloids].
    Gauglitz GG; Pavicic T; Ruzicka T
    MMW Fortschr Med; 2010 Oct; 152(42):40-3; quiz 44. PubMed ID: 21140952
    [No Abstract]   [Full Text] [Related]  

  • 33. Insights into the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ?
    Ghazawi FM; Zargham R; Gilardino MS; Sasseville D; Jafarian F
    Adv Skin Wound Care; 2018 Jan; 31(1):582-595. PubMed ID: 29240586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular basis of keloid and hypertrophic scar formation.
    Tuan TL; Nichter LS
    Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and management of hypertrophic scars and keloids after burns in children.
    Berman B; Viera MH; Amini S; Huo R; Jones IS
    J Craniofac Surg; 2008 Jul; 19(4):989-1006. PubMed ID: 18650721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of keloids and hypertrophic scars.
    Juckett G; Hartman-Adams H
    Am Fam Physician; 2009 Aug; 80(3):253-60. PubMed ID: 19621835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Internet-based survey on current practice for evaluation, prevention, and treatment of scars, hypertrophic scars, and keloids.
    Lumenta DB; Siepmann E; Kamolz LP
    Wound Repair Regen; 2014; 22(4):483-91. PubMed ID: 25041618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keloids and Hypertrophic Scars Can Now Be Cured Completely: Recent Progress in Our Understanding of the Pathogenesis of Keloids and Hypertrophic Scars and the Most Promising Current Therapeutic Strategy.
    Ogawa R; Akaishi S; Kuribayashi S; Miyashita T
    J Nippon Med Sch; 2016; 83(2):46-53. PubMed ID: 27180789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathological scars: what's new?].
    Barak A; Ullman Y; Hor-Shai T; Peled J
    Harefuah; 1996 Aug; 131(3-4):121-5. PubMed ID: 8854499
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacotherapy for Keloids and Hypertrophic Scars.
    Murakami T; Shigeki S
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.